Anglia Ruskin experts want introduction of new treatment model for ductal carcinoma in situ (DCIS) patients

Breast cancer specialists at Anglia Ruskin University are proposing the introduction of a new model to provide safer treatment for patients with ductal carcinoma in situ (DCIS), the most common form of non-invasive breast cancer. Writing in the latest edition of The Lancet Oncology journal, Professor John Benson and Professor Gordon Wishart state that therapies such as radiotherapy and tamoxifen, which can impair quality of life and increase health-care costs, are not necessary for all patients...
Source: Health News from Medical News Today - Category: Consumer Health News Tags: Breast Cancer Source Type: news